S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Global shares mixed amid cautious outlook for global economy

→ Biden replacement revealed? (From Paradigm Press) (Ad)

People wearing face masks walk past a bank's electronic board showing the Hong Kong share index at Hong Kong Stock Exchange in Hong Kong Monday, April 19, 2021. Asian shares were mixed Monday amid cautious optimism about a global rebound from the coronavirus pandemic. (AP Photo/Vincent Yu)

TOKYO (AP) — Global shares were mixed and U.S. futures declined Monday amid cautious optimism about a global rebound from the coronavirus pandemic.

Investors are awaiting a raft of earnings reports this week that will provide further fodder about how businesses are faring.

France's CAC 40 added 0.3% in early trading to 6,305.64, while Germany's DAX inched down less than 0.1% to 15,457.17. Britain's FTSE 100 edged up 0.1% to 7,028.72. U.S. shares were set for a slow start to the week, with Dow futures down 0.3% and the future for the S&P 500 0.2% lower.

Japan's benchmark closed less than 0.1% higher at 29,685.37, in the first Tokyo market reaction to a weekend by Prime Minister Yoshihide Suga with President Joe Biden over the weekend. Suga also spoke with the Pfizer chief executive, asking to ensure a more steady supply of the company's COVID-19 vaccine. Japan has lagged the U.S., Israel and some European nations in a vaccine rollout, with barely 1% of its population inoculated so far.

The government measures against COVID-19 infections already in some urban areas, including Tokyo, are being expanded to other areas of Japan, starting Tuesday, but the cities of Tokyo and Osaka are considering strengthening them to a “state of emergency.” Japan has never had a lockdown, and its laws would need to be changed for such action.

Australia's S&P/ASX 200 inched up less than 0.1% to 7,065.60, while South Korea's Kospi also was little changed, at 3,198.84. Hong Kong's Hang Seng rose 0.5% to 29,106.15. The Shanghai Composite gained 1.5% to 3,477.55.

Even though the possibility of faster delivery of vaccines was a plus, the summit between Biden and Suga has added to tension with China, noted Yoshimasa Maruyama, chief market economist at SMBC Nikko Securities.

“The Suga administration has taken a risk in China relations, in accordance to the U.S. request,” Maruyama said.


Suga may have hoped Biden would more forcefully express support for the Tokyo Olympics, set to open in July despite widespread public objections and worries about the pandemic, but their joint statement merely said the U.S. supports Japan's "efforts to hold a safe and secure" Games.

COVID-19 vaccinations, now reaching half of the U.S. population, and massive support from the U.S. government and Federal Reserve are fueling expectations for solid corporate profit growth as more businesses reopen.

The last round of stimulus from the government helped lift retail sales, and investors now have to weigh other proposals in Washington, which include investments in infrastructure and potential tax changes.

Investors also are focusing on earnings, with dozens of U.S. companies due to report results this week, including Coca-Cola, Johnson & Johnson, Verizon Communications, Dow Chemical and American Airlines.

In energy trading, benchmark U.S. crude fell 7 cents to $63.12 a barrel in electronic trading on the New York Mercantile Exchange. It lost 32 cents to $63.19 per barrel on Friday. Brent crude, the international standard, was unchanged at $66.77 a barrel.

In currency trading, the U.S. dollar edged down to 108.07 Japanese yen from 108.78 yen late Friday. The euro rose to $1.2022 from $1.1978.

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Should you invest $1,000 in Johnson & Johnson right now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)
4.9926 of 5 stars
$25.41-1.1%6.61%70.57Hold$36.88
Johnson & Johnson (JNJ)
4.5956 of 5 stars
$144.77+0.2%3.29%10.48Hold$177.31
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: